BNT162c2 SARS-CoV-2 Vaccine

Ask the supplier | View on supplier's website

BNT162c2 is one of four advanced mRNA-based vaccines being developed through \"Project Lightspeed,\" a joint program between Pfizer and BioNTech. BNT162c2 is a self-amplifying mRNA (saRNA) vaccine formulated in lipid nanoparticles for delivery via intramuscular injection.BNT162c2 is undergoing evaluation in clinical trials in both the USA (NCT04368728) and Germany (NCT04380701).

Supplier	Creative Biomart
Product #	INB-326
Pricing	1 vial : USD $998

Feedback